Article
Are you up-to-date on the latest recommendations for PsA from EULAR and GRAPPA? Take our 6-question quiz to find out.
New evidence and the availability of novel therapeutic agents prompted the European League Against Rheumatism (EULAR)1,2 and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)3,4 to update their practice recommendations for psoriatic arthritis (PsA) in 2015.
How well do you know the latest EULAR and GRAPPA guidelines on PsA? Test your knowledge with this 6-question quiz.
1. GRAPPA 2015 included updated treatment recommendations for which of the following symptoms of PsA?
A. Arthritis and spondylitis
B. Enthesitis and dactylitis
C. Skin and nail disease
D. All of the above
1. Gossec L, Smolen JS, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012;71:4-12.
2. Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499-510.
3. Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68:1060-1071.
4. Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol. 2016;68:1060-1071.
Links to Full Text of Guidelines:
EULAR 2015: http://ard.bmj.com/content/75/3/499.long
GRAPPA 2015: https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.39573